Following non-submission
AWMSG advice |
||
| Status: Not endorsed (Statement of Advice) | ||
In the absence of a submission from the holder of the marketing authorisation, glycopyrronium bromide cannot be endorsed for use within NHS Wales for use in adults as add-on therapy in the treatment of peptic ulcer. |
||
|
||
Medicine details |
||
| Medicine name | glycopyrronium bromide (Assicco®) | |
| Formulation | 1 mg and 2 mg tablet | |
| Reference number | 2530 | |
| Indication | In adults as add-on therapy in the treatment of peptic ulcer |
|
| Company | Morningside Healthcare Ltd | |
| BNF chapter | Gastro-intestinal system | |
| Assessment type | Non-submission | |
| Status | Not endorsed (Statement of Advice) | |
| Date of issue | 24/09/2014 | |